The expression of CSRP2 encoding the LIM domain protein CRP2 is mediated by TGF-β in smooth muscle and hepatic stellate cells

Biochemical and Biophysical Research Communications

Volumn 345, Issue 4, 2006, Pages 1526-1535

  Herrmann, Jens ^a   Borkham Kamphorst, Erawan ^a   Haas, Ute ^a   Van de Leur, Eddy ^a   Fraga, Mario F ^b   Esteller, Manel ^b   Gressner, Axel M ^a   Weiskirchen, Ralf ^a  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^b Centro Nacional de Investigaciones Oncológicas   (Spain)

Author keywords

Bisulfite genomic analysis; Cysteine and glycine rich protein; Gene regulation; Hepatic stellate cell; LIM domain proteins; Smad proteins; Smooth muscle cell; Transforming growth factor

Indexed keywords

4 [4 (1,3 BENZODIOXOL 5 YL) 5 (2 PYRIDINYL) 1H IMIDAZOL 2 YL]BENZAMIDE; BISULFITE; CYSTEINE RICH AND GLYCINE RICH LIM DOMAIN PROTEIN 2; LIM PROTEIN; PROTEIN INHIBITOR; SMAD2 PROTEIN; SMAD3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 1; UNCLASSIFIED DRUG;

5' UNTRANSLATED REGION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL; CANCER STAGING; CARCINOGENESIS; CELL DIFFERENTIATION; CELL STIMULATION; CONTROLLED STUDY; CPG ISLAND; EMBRYO; GENE EXPRESSION; GENE INACTIVATION; GENE SILENCING; GENETIC ANALYSIS; GENETIC CODE; GENOMICS; LIVER CELL; MALE; MYOFIBROBLAST; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; RAT; REGULATOR GENE; RNA METHYLATION; SIGNAL TRANSDUCTION; SMOOTH MUSCLE; STELLATE CELL; TRANSCRIPTION INITIATION;

ACTIVIN RECEPTORS, TYPE I; ANIMALS; BASE SEQUENCE; BENZAMIDES; BLOTTING, NORTHERN; BLOTTING, WESTERN; CELL LINE; CELLS, CULTURED; DIOXOLES; DNA METHYLATION; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; LIVER; LIVER CIRRHOSIS; MALE; MOLECULAR SEQUENCE DATA; MUSCLE PROTEINS; MUSCLE, SMOOTH, VASCULAR; NUCLEAR PROTEINS; PROMOTER REGIONS (GENETICS); RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; RNA, MESSENGER; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; UP-REGULATION;

EID: 33744528276     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2006.05.076     Document Type: Article

References (57)

1. Weiskirchen R., Pino J.D., Macalma T., Bister K., and Beckerle M.C. The cysteine-rich protein family of highly related LIM domain proteins. J. Biol. Chem. 270 (1995) 28946-28954
2. Weiskirchen R., and Günther K. The CRP/MLP/TLP family of LIM domain proteins: acting by connecting. Bioessays 25 (2003) 152-162
3. Sadler I., Crawford A.W., Michelsen J.W., and Beckerle M.C. Zyxin and cCRP: two interactive LIM domain proteins associated with the cytoskeleton. J. Cell Biol. 119 (1992) 1573-1587
4. Arber S., and Caroni P. Specificity of single LIM motifs in targeting and LIM/LIM interactions in situ. Genes Dev. 10 (1996) 289-300
5. Pomies P., Louis H.A., and Beckerle M.C. CRP1, a LIM domain protein implicated in muscle differentiation, interacts with α-actinin. J. Cell Biol. 139 (1997) 157-168
6. Louis H.A., Pino J.D., Schmeichel K.L., Pomies P., and Beckerle M.C. Comparison of three members of the cysteine-rich protein family reveals functional conservation and divergent patterns of gene expression. J. Biol. Chem. 272 (1997) 27484-27491
7. Grubinger M., and Gimona M. CRP2 is an autonomous actin-binding protein. FEBS Lett. 557 (2004) 88-92
8. Jain M.K., Fujita K.P., Hsieh C.M., Endege W.O., Sibinga N.E., Yet S.F., Kashiki S., Lee W.S., Perrella M.A., Haber E., and Lee M.E. Molecular cloning and characterization of SmLIM, a developmentally regulated LIM protein preferentially expressed in aortic smooth muscle cells. J. Biol. Chem. 271 (1996) 10194-10199
9. Weiskirchen R., Moser M., Weiskirchen S., Erdel M., Dahmen S., Buettner R., and Gressner A.M. LIM-domain protein cysteine- and glycine-rich protein 2 (CRP2) is a novel marker of hepatic stellate cells and binding partner of the protein inhibitor of activated STAT1. Biochem. J. 359 (2001) 485-496
10. Kirchner J., Forbush K.A., and Bevan M.J. Identification and characterization of thymus LIM protein: targeted disruption reduces thymus cellularity. Mol. Cell. Biol. 21 (2001) 8592-8604
11. Kong Y., Flick M.J., Kudla A.J., and Konieczny S.F. Muscle LIM protein promotes myogenesis by enhancing the activity of MyoD. Mol. Cell. Biol. 17 (1997) 4750-4760
12. Chang D.F., Belaguli N.S., Iyer D., Roberts W.B., Wu S.P., Dong X.R., Marx J.G., Moore M.S., Beckerle M.C., Majesky M.W., and Schwartz R.J. Cysteine-rich LIM-only proteins CRP1 and CRP2 are potent smooth muscle differentiation cofactors. Dev. Cell 4 (2003) 107-118
13. Arber S., Hunter J.J., Ross Jr. J., Hongo M., Sansig G., Borg J., Perriard J.C., Chien K.R., and Caroni P. MLP-deficient mice exhibit a disruption of cardiac cytoarchitectural organization, dilated cardiomyopathy, and heart failure. Cell 88 (1997) 393-403
14. Ehler E., Horowits R., Zuppinger C., Price R.L., Perriard E., Leu M., Caroni P., Sussman M., Eppenberger H.M., and Perriard J.C. Alterations at the intercalated disk associated with the absence of muscle LIM protein. J. Cell Biol. 153 (2001) 763-772
15. Wei J., Gorman T.E., Liu X., Ith B., Tseng A., Chen Z., Simon D.I., Layne M.D., and Yet S.F. Increased neointima formation in cysteine-rich protein 2-deficient mice in response to vascular injury. Circ. Res. 97 (2005) 1323-1331
16. J.F. Ludewig, M. Moser, E. Ehler, S. Weiskirchen, D. Stoll, K. Günter, R. Büttner, A.M. Gressner, R. Weiskirchen, Targeted disruption of the mouse Csrp2 gene encoding the cysteine-and glycine rich LIM domain protein CRP2 result in subtle alteration of cardiac ultrastructure, submitted for publication.
17. Wang X., Lee G., Liebhaber S.A., and Cooke N.E. Human cysteine-rich protein. A member of the LIM/double-finger family displaying coordinate serum induction with c-myc. J. Biol. Chem. 267 (1992) 9176-9184
18. Lilly B., Olson E.N., and Beckerle M.C. Identification of a CArG box-dependent enhancer within the cysteine-rich protein 1 gene that directs expression in arterial but not venous or visceral smooth muscle cells. Dev. Biol. 240 (2001) 531-547
19. 2+/calmodulin-dependent protein kinase IV activates cysteine-rich protein 1 through adjacent CRE and CArG elements. Am. J. Physiol. Cell Physiol. 289 (2005) C785-C793
20. Watanabe T., Akishita M., Nakaoka T., He H., Miyahara Y., Yamashita N., Wada Y., Aburatani H., Yoshizumi M., Kozaki K., and Ouchi Y. Caveolin-1, Id3a and two LIM protein genes are upregulated by estrogen in vascular smooth muscle cells. Life Sci. 75 (2004) 1219-1229
21. Sullivan Jr. T.R., Karas R.H., Aronovitz M., Faller G.T., Ziar J.P., Smith J.J., O'Donnell Jr. T.F., and Mendelsohn M.E. Estrogen inhibits the response-to-injury in a mouse carotid artery model. J. Clin. Invest. 96 (1995) 2482-2488
22. Chang Y.F., Wei J., Liu X., Chen Y.H., Layne M.D., and Yet S.F. Identification of a CArG-independent region of the cysteine-rich protein 2 promoter that directs expression in the developing vasculature. Am. J. Physiol. Heart Circ. Physiol. 285 (2003) H1675-H1683
23. Balza Jr. R.O., and Misra R.P. Role of the serum response factor in regulating contractile apparatus gene expression and sarcomeric integrity in cardiomyocytes. J. Biol. Chem. 281 (2006) 6498-6510
24. Yet S.F., Folta S.C., Jain M.K., Hsieh C.M., Maemura K., Layne M.D., Zhang D., Marria P.B., Yoshizumi M., Chin M.T., Perrella M.A., and Lee M.E. Molecular cloning, characterization, and promoter analysis of the mouse Crp2/SmLim gene. Preferential expression of its promoter in the vascular smooth muscle cells of transgenic mice. J. Biol. Chem. 273 (1998) 10530-10537
25. Layne M.D., Yet S.F., Maemura K., Hsieh C.M., Liu X., Ith B., Lee M.E., and Perrella M.A. Characterization of the mouse aortic carboxypeptidase-like protein promoter reveals activity in differentiated and dedifferentiated vascular smooth muscle cells. Circ. Res. 90 (2002) 728-736
26. Weiskirchen R., and Bister K. Suppression in transformed avian fibroblasts of a gene (crp) encoding a cysteine-rich protein containing LIM domains. Oncogene 8 (1993) 2317-2324
27. Neyzen S., Van de Leur E., Borkham-Kamphorst E., Herrmann J., Hollweg G., Gressner A.M., and Weiskirchen R. Cryopreservation of hepatic stellate cells. J. Hepatol. 44 (2006) 910-917
28. Gressner A.M., and Weiskirchen R. Modern pathogenetic concepts of liver fibrosis suggest stellate cells and TGF-β as major players and therapeutic targets. J. Cell. Mol. Med. 10 (2006) 76-99
29. Rockey D.C., Boyles J.K., Gabbiani G., and Friedman S.L. Rat hepatic lipocytes express smooth muscle actin upon activation in vivo and in culture. J. Submicrosc. Cytol. Pathol. 24 (1992) 193-203
30. Weiskirchen R., Abriss B., Arias M., Kneifel J., van de Leur E., Weiskirchen S., and Gressner A.M. Experimental approaches to antifibrotic strategies using gene transfer. In: Gressner A.M., Heinrich P.C., and Matern S. (Eds). Progress in Gastroeneterology and Hepatology; Cytokines in Liver Injury and Repair (2002), Kluwer, Dordrecht, The Netherlands 335-353
31. Herrmann J., Arias M., van de Leur E., Gressner A.M., and Weiskirchen R. CSRP2, TIMP-1, and SM22α promoter fragments direct hepatic stellate cell-specific transgene expression in vitro, but not in vivo. Liver Int. 24 (2004) 69-79
32. Shah N.M., Groves A.K., and Anderson D.J. Alternative neural crest cell fates are instructively promoted by TGFβ superfamily members. Cell 85 (1996) 331-343
33. Hirschi K.K., Rohovsky S.A., and D'Amore P.A. PDGF, TGF-β, and heterotypic cell-cell interactions mediate endothelial cell-induced recruitment of 10T1/2 cells and their differentiation to a smooth muscle fate. J. Cell Biol. 141 (1998) 805-814
34. Hautmann M.B., Madsen C.S., and Owens G.K. A transforming growth factor β (TGFβ) control element drives TGFβ-induced stimulation of smooth muscle α-actin gene expression in concert with two CArG elements. J. Biol. Chem. 272 (1997) 10948-10956
35. Adam P.J., Regan C.P., Hautmann M.B., and Owens G.K. Positive- and negative-acting Krüppel-like transcription factors bind a transforming growth factor β control element required for expression of the smooth muscle cell differentiation marker SM22α in vivo. J. Biol. Chem. 275 (2000) 37798-37806
36. de Leeuw A.M., McCarthy S.P., Geerts A., and Knook D.L. Purified rat liver fat-storing cells in culture divide and contain collagen. Hepatology 4 (1984) 392-403
37. Schafer S., Zerbe O., and Gressner A.M. The synthesis of proteoglycans in fat-storing cells of rat liver. Hepatology 7 (1987) 680-687
38. Seglen P.O. Preparation of isolated rat liver cells. Methods Cell. Biol. 13 (1976) 29-83
39. Rao R.S., Miano J.M., Olson E.N., and Seidel C.L. The A10 cell line: a model for neonatal, neointimal, or differentiated vascular smooth muscle cells?. Cardiovasc. Res. 36 (1997) 118-126
40. Greenwel P., Schwartz M., Rosas M., Peyrol S., Grimaud J.A., and Rojkind M. Characterization of fat-storing cell lines derived from normal and CCl4-cirrhotic livers. Differences in the production of interleukin-6. Lab. Invest. 65 (1991) 644-653
41. Fraga M.F., Herranz M., Espada J., Ballestar E., Paz M.F., Ropero S., Erkek E., Bozdogan O., Peinado H., Niveleau A., Mao J.H., Balmain A., Cano A., and Esteller M. A mouse skin multistage carcinogenesis model reflects the aberrant DNA methylation patterns of human tumors. Cancer Res. 64 (2004) 5527-5534
42. Lebrin F., Deckers M., Bertolino P., and ten Dijke P. TGF-β receptor function in the endothelium. Cardiovasc. Res. 65 (2005) 599-608
43. Chen S., Kulik M., and Lechleider R.J. Smad proteins regulate transcriptional induction of the SM22α gene by TGF-β. Nucleic Acids Res. 31 (2003) 1302-1310
44. Callahan J.F., Burgess J.L., Fornwald J.A., Gaster L.M., Harling J.D., Harrington F.P., Heer J., Kwon C., Lehr R., Mathur A., Olson B.A., Weinstock J., and Laping N.J. Identification of novel inhibitors of the transforming growth factor β1 (TGF-β1) type 1 receptor (ALK5). J. Med. Chem. 45 (2002) 999-1001
45. Missero C., Ramon y Cajal S., and Dotto G.P. Escape from transforming growth factor β control and oncogene cooperation in skin tumor development. Proc. Natl. Acad. Sci. USA 88 (1991) 9613-9617
46. Grainger D.J., Metcalfe J.C., Grace A.A., and Mosedale D.E. Transforming growth factor-β dynamically regulates vascular smooth muscle differentiation in vivo. J. Cell Sci. 111 (1998) 2977-2988
47. Deaton R.A., Su C., Valencia T.G., and Grant S.R. Transforming growth factor-β1-induced expression of smooth muscle marker genes involves activation of PKN and p38 MAPK. J. Biol. Chem. 280 (2005) 31172-31181
48. Dooley S., Delvoux B., Streckert M., Bonzel L., Stopa M., ten Dijke P., and Gressner A.M. Transforming growth factor β signal transduction in hepatic stellate cells via Smad2/3 phosphorylation, a pathway that is abrogated during in vitro progression to myofibroblasts. TGFβ signal transduction during transdifferentiation of hepatic stellate cells. FEBS Lett. 502 (2001) 4-10
49. Hautmann M.B., Adam P.J., and Owens G.K. Similarities and differences in smooth muscle α-actin induction by TGF-β in smooth muscle versus non-smooth muscle cells. Arterioscler. Thromb. Vasc. Biol. 19 (1999) 2049-2058
50. Dennler S., Itoh S., Vivien D., ten Dijke P., Huet S., and Gauthier J.M. Direct binding of Smad3 and Smad4 to critical TGF β-inducible elements in the promoter of human plasminogen activator inhibitor-type 1 gene. EMBO J. 17 (1998) 3091-3100
51. Qiu P., Feng X.H., and Li L. Interaction of Smad3 and SRF-associated complex mediates TGF-β1 signals to regulate SM22 transcription during myofibroblast differentiation. J. Mol. Cell. Cardiol. 35 (2003) 1407-1420
52. Tsukada S., Westwick J.K., Ikejima K., Sato N., and Rippe R.A. SMAD and p38 MAPK signaling pathways independently regulate α1(I) collagen gene expression in unstimulated and transforming growth factor-β-stimulated hepatic stellate cells. J. Biol. Chem. 280 (2005) 10055-10064
53. van Grunsven L.A., Verstappen G., Huylebroeck D., and Verschueren K. Smads and chromatin modulation. Cytokine Growth Factor Rev. 16 (2005) 495-512
54. Qiu P., and Li L. Histone acetylation and recruitment of serum responsive factor and CREB-binding protein onto SM22 promoter during SM22 gene expression. Circ. Res. 90 (2002) 858-865
55. Hirschi K.K., Lai L., Belaguli N.S., Dean D.A., Schwartz R.J., and Zimmer W.E. Transforming growth factor-β induction of smooth muscle cell phenotype requires transcriptional and post-transcriptional control of serum response factor. J. Biol. Chem. 277 (2002) 6287-6295
56. Qiu P., Feng X.H., and Li L. Interaction of Smad3 and SRF-associated complex mediates TGF-β1 signals to regulate SM22 transcription during myofibroblast differentiation. J. Mol. Cell. Cardiol. 35 (2003) 1407-1420
57. Cao D., Wang Z., Zhang C.L., Oh J., Xing W., Li S., Richardson J.A., Wang D.Z., and Olson E.N. Modulation of smooth muscle gene expression by association of histone acetyltransferases and deacetylases with myocardin. Mol. Cell. Biol. 25 (2005) 364-376